These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32157015)

  • 41. [The Efficacy of Neoadjuvant Chemoradiation Therapy for Borderline Resectable Pancreatic Cancer].
    Sano T; Takano K; Chiba N; Tomita K; Ozawa Y; Hikita K; Shimazu M; Kawachi S
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):1488-90. PubMed ID: 26805072
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neoadjuvant FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer: An intention to treat analysis.
    Barenboim A; Lahat G; Geva R; Nachmany I; Nakache R; Goykhman Y; Brazowski E; Rosen G; Isakov O; Wolf I; Klausner JM; Lubezky N
    Eur J Surg Oncol; 2018 Oct; 44(10):1619-1623. PubMed ID: 30146251
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A case of pathological complete response with liposomal irinotecan + 5-FU/LV for unresectable locally advanced pancreatic cancer.
    Kikuchi K; Umemura A; Nitta H; Katagiri H; Nishiya M; Uesugi N; Sugai T; Imanari K; Sasaki A
    Surg Case Rep; 2022 Oct; 8(1):192. PubMed ID: 36205833
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Neoadjuvant FOLFIRINOX for Unresectable Adenocarcinoma of the Pancreas - A Case Report].
    Ochiai T; Inoue H; Nakatsuji H; Watanabe N; Yoshiyama A; Ito H; Toma A; Nakamura K
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1349-1351. PubMed ID: 29394630
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Modified Appleby procedure for borderline resectable/locally advanced distal pancreatic adenocarcinoma: A major procedure for selected patients.
    Cesaretti M; Abdel-Rehim M; Barbier L; Dokmak S; Hammel P; Sauvanet A
    J Visc Surg; 2016 Jun; 153(3):173-81. PubMed ID: 26775202
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [A Long-Term Survival Case of Locally Advanced Unresectable Pancreatic Adenocarcinoma after Chemoradiotherapy and Conversion Surgery].
    Ohmura Y; Takeda Y; Katsura Y; Shinke G; Kihara Y; Haruna K; Kusafuka H; Sakaue M; Katsuyama S; Kawai K; Hiraki M; Masuzawa T; Takeno A; Hata T; Murata K
    Gan To Kagaku Ryoho; 2021 Dec; 48(13):1999-2001. PubMed ID: 35045473
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Pure laparoscopic DP-CAR procedure with portal vein resection].
    Voskanyan SE; Shabalin MV; Artemiyev AI; Kolyshev IY; Bogoevich Z; Kucherov NN; Bashkov AN; Naydenov EV
    Khirurgiia (Mosk); 2019; (9):93-98. PubMed ID: 31532174
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Locally advanced pancreatic adenocarcinoma: reassessment of response with CT after neoadjuvant chemotherapy and radiation therapy.
    Cassinotto C; Mouries A; Lafourcade JP; Terrebonne E; Belleannée G; Blanc JF; Lapuyade B; Vendrely V; Laurent C; Chiche L; Wagner T; Sa-Cunha A; Gaye D; Trillaud H; Laurent F; Montaudon M
    Radiology; 2014 Oct; 273(1):108-16. PubMed ID: 24960211
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Successful treatment of a locally advanced unresectable pancreatic cancer patient with interstitial pneumonitis by conversion surgery following gemcitabine plus nab-paclitaxel chemotherapy: A case report.
    Yokota T; Takano S; Yoshitomi H; Kagawa S; Furukawa K; Takayashiki T; Kuboki S; Suzuki D; Sakai N; Nojima H; Mishima T; Nakadai E; Ohtsuka M
    Mol Clin Oncol; 2019 Apr; 10(4):419-424. PubMed ID: 30931110
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Total Pancreatectomy for Remnant Pancreatic Cancer with Positive Washing Cytology after Conversion to Negative Cytology Following Gemcitabine plus Nab-Paclitaxel Therapy-A Case Report].
    Nakajima K; Maruyama T; Aono T; Suzuki S; Kaneko K; Sato T; Okada T; Muto I; Hasegawa M; Muneoka Y; Tajima Y; Ichikawa H; Shimada Y; Sakata J; Wakai T
    Gan To Kagaku Ryoho; 2022 Dec; 49(13):1681-1683. PubMed ID: 36733175
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Full dose neoadjuvant FOLFIRINOX is associated with prolonged survival in patients with locally advanced pancreatic adenocarcinoma.
    Khushman M; Dempsey N; Maldonado JC; Loaiza-Bonilla A; Velez M; Carcas L; Dammrich D; Hurtado-Cordovi J; Parajuli R; Pollack T; Harwood AP; Macintyre J; Tzeng CW; Merchan JR; Restrepo MH; Akunyili II; Ribeiro A; Narayanan G; Portelance L; Sleeman D; Levi JU; Lima CM; Hosein PJ
    Pancreatology; 2015; 15(6):667-73. PubMed ID: 26412296
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [A Case of Pancreatic Head Cancer Resected after Neoadjuvant Chemotherapy Followed by Pseudocyst].
    Kawaoka T; Saeki S; Nishida Y; Tokunou K; Tamesa T; Miyahara M; Yamamoto S; Nabeya M; Kubo H
    Gan To Kagaku Ryoho; 2019 Dec; 46(13):2021-2023. PubMed ID: 32157046
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systematic Review of Resection Rates and Clinical Outcomes After FOLFIRINOX-Based Treatment in Patients with Locally Advanced Pancreatic Cancer.
    Rombouts SJ; Walma MS; Vogel JA; van Rijssen LB; Wilmink JW; Mohammad NH; van Santvoort HC; Molenaar IQ; Besselink MG
    Ann Surg Oncol; 2016 Dec; 23(13):4352-4360. PubMed ID: 27370653
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Distal pancreatectomy with en bloc celiac axis resection for locally advanced pancreatic body cancer: long-term results.
    Hirano S; Kondo S; Hara T; Ambo Y; Tanaka E; Shichinohe T; Suzuki O; Hazama K
    Ann Surg; 2007 Jul; 246(1):46-51. PubMed ID: 17592290
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Appleby operation for locally advanced tumour of the pancreatic body and tail--a video demonstration].
    Grützmann R; Distler M; Weitz J
    Zentralbl Chir; 2015 Apr; 140(2):151-4. PubMed ID: 25874466
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Borderline and locally advanced pancreatic adenocarcinoma margin accentuation with intraoperative irreversible electroporation.
    Kwon D; McFarland K; Velanovich V; Martin RC
    Surgery; 2014 Oct; 156(4):910-20. PubMed ID: 25239345
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Distal Pancreatectomy with en Bloc Celiac Axis Resection (Modified Appleby Procedure) for Locally Advanced Pancreatic Body Cancer: A Single-Center Review of 80 Consecutive Patients.
    Nakamura T; Hirano S; Noji T; Asano T; Okamura K; Tsuchikawa T; Murakami S; Kurashima Y; Ebihara Y; Nakanishi Y; Tanaka K; Shichinohe T
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):969-975. PubMed ID: 27495282
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Laparoscopic Liver Resection for Liver Metastasis from Unresectable Pancreatic Ductal Adenocarcinoma Well-Controlled by Chemotherapy-A Case Report].
    Nobori C; Tsukamoto T; Nishiyama T; Kunimoto T; Kaizaki R; Inoue T; Nishiguchi Y
    Gan To Kagaku Ryoho; 2020 Dec; 47(13):1881-1883. PubMed ID: 33468860
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical Characteristics of Patients Experiencing Pathologic Complete Response Following Neoadjuvant Therapy for Borderline Resectable/Locally Advanced Pancreatic Adenocarcinoma.
    Hashemi-Sadraei N; Gbolahan OB; Salfity H; O'Neil B; House MG; Shahda S
    Am J Clin Oncol; 2018 Oct; 41(10):982-985. PubMed ID: 28968257
    [TBL] [Abstract][Full Text] [Related]  

  • 60. FOLFIRINOX-based neoadjuvant therapy in borderline resectable or unresectable pancreatic cancer: a meta-analytical review of published studies.
    Petrelli F; Coinu A; Borgonovo K; Cabiddu M; Ghilardi M; Lonati V; Aitini E; Barni S;
    Pancreas; 2015 May; 44(4):515-21. PubMed ID: 25872127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.